Diagnostics Development and Novel Technology Development and Evaluation to Improve Diagnostic Testing Capabilities for COVID-19 Detection
Award amount
$1,990,393Program and phase
SBIR · Phase II – Direct to Phase IIAward year
2020Award details
- Awarding agency
- Department of Defense
- Branch
- Air Force
- Recipient company
- BOTANISOL ANALYTICS, INC.
- Proposal award date
- 2020-06-29
- Contract end date
- 2020-12-29
- UEI
- VAQKP4LEARF2
- Solicitation number
- X20.R
- Topic code
- AF20R-DCSO1
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Validating a new Hydrogen Lyman-Alpha Line (HLA) spectrometer as an instant diagnostic and threat detection system.
- REAL TIME ACQUISITION OF CHEMICAL THREAT MATERIALS AT CLOSE PROXIMAL RANGES
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- A Defect and Damage Inspection Tool for Incoming Part Inspection
- REAFFIRM: Reverse Engineer, Analyze, and Fix Firmware
- Applying Computational Game Theory AI to Many-v-Many BVR Air Combat
- Tetrate TACFI
- Proliferated Geostationary Earth Orbit (GEO) Satellite Communications (SATCOM)
Research funding history
3 SBIR/STTR records share this UEI (2019–2020). Reported award amounts total $3,539,884. Reported amounts are not federal obligations.
Phases: Phase II – Direct to Phase II, Phase I
Agencies: Department of Defense